Using SCIT vs. SLIT to  Modify Allergic Disease
Sunday, March 6, 2016: 10:45 AM-12:00 PM
Convention Center, Level Two, Room 502A
1.25 CME/CE
Linda Cox , MD FAAAAI

Learning Objectives:
  1. Discuss the latest data on the efficacy and safety of SCIT compared to SLIT for grass pollen allergy
  2. Identify several newly discovered biomarkers for AIT efficacy
  3. Discuss and explain safety and adherence issues of SLIT and SCIT and utilize resources to try to overcome them
10:45 AM
SCIT vs. SLIT: Efficacy in Clinical Trials
Stephen R. Durham, MA MD FRCP
11:05 AM
Question & Answer
11:10 AM
Nasal and Systemic Biomarkers for Immunotherapy Efficacy: Lessons Learned from the SLIT-SCIT Trial
Mohamed H. Shamji, PhD FAAAAI
11:30 AM
Question & Answer
11:35 AM
SLIT-SCIT Safety and Adherence: Do They Matter?
Giovanni Passalacqua, MD
  • LOSANGELES2016-hand.pdf (2.8 MB)
  • 11:55 AM
    Question & Answer
    See more of: Session